Tag Archive for: Versameb AG

Versameb: Revolutionizing SUI therapy with mRNA technology

Stress urinary incontinence (SUI) is a common and debilitating problem for many women, particularly after childbirth or in later years. Yet despite this treatment options are limited, held back by a lack of research into medical products focused on women’s health. But one biotech, Versameb, hopes to change this with a novel mRNA therapy that […]

The promise of mRNA therapeutics in producing the first regenerative treatment for SUI

Article by Dr Roger Dmochowski, Professor of Urology & Advisory Board Member of Versameb